Is the price fair?
What CORZ's price assumes
Core Scientific, Inc. did not earn a profit over the last twelve months, so it has no trailing P/E and the price is read against sales instead: 13.6× revenue.
13.6
Price / sales · no P/E: the last twelve months did not end in a profit
- EV / sales
- 13.8
EV / sales
Details›
- EV / EBIToperating margin −127%: the multiple describes the denominator
- not meaningful
- EV / sales2026-Q1
- 13.8
- Market capitalisation
- $9.27B
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
Software - Infrastructure
Ranks #62 of 78 by Smart Score